Yu Kitazawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Yu Kitazawa has a total of 121 co-authors. Here are the top co-authors by number of shared publications:
- Eishi Asano
Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center Wayne State University Detroit Michigan USA
4 shared publications - Naoto Kuroda
Department of Epileptology Tohoku University Graduate School of Medicine Sendai Japan
4 shared publications Riyo Ueda
Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, Michigan, 48201, USA. Department of Neurosurgery, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, 1878551, Japan
4 shared publications- Hiroshi Uda
Department of Pediatrics, Children's Hospital of Michigan, Detroit Medical Center, Wayne State University, Detroit, MI 48201, USA; Department of Neurosurgery, Osaka Metropolitan University Graduate School of Medicine, Osaka 5458585, Japan
3 shared publications - Daichi Sone
Department of Radiology National Center of Neurology and Psychiatry Tokyo Japan
2 shared publications - Erena Kobayashi
Department of Neurology and Stroke Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan
2 shared publications
Latest Publications
- 10 October 2026
- Published by Springer Nature in The Cerebellum
- Vol. 25 (5) , 155
Three-dimensional Motion Capture Discriminates Extremely Mild Cerebellar Ataxia from Parkinsonism in the Upper Limbs
- 10 October 2026
- Published by Springer Nature in The Cerebellum
- Vol. 25 (5) , 155
Three-dimensional Motion Capture Discriminates Extremely Mild Cerebellar Ataxia from Parkinsonism in the Upper Limbs
- Open Access
- 8 April 2026
- Published by Elsevier in SSRN Electronic Journal
Three-dimensional motion capture discriminates extremely mild cerebellar ataxia from parkinsonism in the upper limbs
BackgroundUpper-limb motor symptoms in spinocerebellar degeneration (SCD) and Parkinson’s disease (PD) often overlap, making differentiation challenging in mild cases based on clinical observation of the finger-to-nose test (FNT) or the diadochokinesis test (DDKT). This study aimed to identify quantitative kinematic markers that distinguish mild SCD from mild PD using three-dimensional (3D) motion capture.MethodsTwenty-six patients with mild SCD, 26 with mild PD, and 26 normal controls (NCs) underwent motion analysis during the FNT-forward, FNT-backward, and DDKT. Key parameters, including segmental velocity ratios during the FNT and rotational angle parameters during the DDKT, were analyzed. Significant parameters were validated in an additional cohort of 20 patients with moderate-to-severe SCD, and 23 with moderate-to-severe PD, and associations with motor rating scores were examined.ResultsDuring the FNT-forward, the velocity ratio in the final one-third of the movement was significantly higher in patients with mild SCD than in those with mild PD and NCs and correlated with dysmetria scores in the moderate-to-severe SCD group. During the DDKT, patients with mild PD showed smaller rotation angles and a greater decline over time than patients with mild SCD and NCs. This reduction correlated with akinesia scores in the moderate-to-severe PD group.ConclusionThree-dimensional motion capture identified disease-specific kinematic features not detectable by visual inspection. Mild SCD was characterized by increased terminal velocity during FNT-forward, reflecting subtle dysmetria, whereas mild PD showed reduced rotation amplitude during the DDKT, reflecting early akinesia. These markers may support early differential diagnosis and upper-limb motor assessment.
- 8 April 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessThree-dimensional motion capture discriminates extremely mild cerebellar ataxia from parkinsonism in the upper limbs
BackgroundUpper-limb motor symptoms in spinocerebellar degeneration (SCD) and Parkinson’s disease (PD) often overlap, making differentiation challenging in mild cases based on clinical observation of the finger-to-nose test (FNT) or the diadochokinesis test (DDKT). This study aimed to identify quantitative kinematic markers that distinguish mild SCD from mild PD using three-dimensional (3D) motion capture.MethodsTwenty-six patients with mild SCD, 26 with mild PD, and 26 normal controls (NCs) underwent motion analysis during the FNT-forward, FNT-backward, and DDKT. Key parameters, including segmental velocity ratios during the FNT and rotational angle parameters during the DDKT, were analyzed. Significant parameters were validated in an additional cohort of 20 patients with moderate-to-severe SCD, and 23 with moderate-to-severe PD, and associations with motor rating scores were examined.ResultsDuring the FNT-forward, the velocity ratio in the final one-third of the movement was significantly higher in patients with mild SCD than in those with mild PD and NCs and correlated with dysmetria scores in the moderate-to-severe SCD group. During the DDKT, patients with mild PD showed smaller rotation angles and a greater decline over time than patients with mild SCD and NCs. This reduction correlated with akinesia scores in the moderate-to-severe PD group.ConclusionThree-dimensional motion capture identified disease-specific kinematic features not detectable by visual inspection. Mild SCD was characterized by increased terminal velocity during FNT-forward, reflecting subtle dysmetria, whereas mild PD showed reduced rotation amplitude during the DDKT, reflecting early akinesia. These markers may support early differential diagnosis and upper-limb motor assessment.
- Open Access
- 2 July 2025
- Published by Elsevier in NeuroImage
- Vol. 317, 121352
Millisecond-Scale White Matter Dynamics Underlying Visuomotor Integration
- 2 July 2025
- Published by Elsevier in NeuroImage
- Vol. 317, 121352
Open AccessMillisecond-Scale White Matter Dynamics Underlying Visuomotor Integration
- 21 April 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 175, 2010729
Visualization of functional and effective connectivity underlying auditory descriptive naming
- 21 April 2025
- Published by Elsevier in Clinical Neurophysiology
- Vol. 175, 2010729
Visualization of functional and effective connectivity underlying auditory descriptive naming
- 18 March 2024
- Published by Elsevier in Clinical Neurophysiology
- Vol. 162, 9-27
Cortical and white matter substrates supporting visuospatial working memory
- 18 March 2024
- Published by Elsevier in Clinical Neurophysiology
- Vol. 162, 9-27
Cortical and white matter substrates supporting visuospatial working memory
- Open Access
- 22 February 2023
- Published by Elsevier in NeuroImage
- Vol. 270, 119954
Intra– and inter–hemispheric network dynamics supporting object recognition and speech production
- 22 February 2023
- Published by Elsevier in NeuroImage
- Vol. 270, 119954
Open AccessIntra– and inter–hemispheric network dynamics supporting object recognition and speech production
- 22 June 2022
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 123 (4) , 1531-1532
Relapse of myelin oligodendrocyte glycoprotein antibody-associated demyelinating disease in an elderly patient after long-term remission
- 22 June 2022
- Published by Springer Nature in Acta Neurologica Belgica
- Vol. 123 (4) , 1531-1532
Relapse of myelin oligodendrocyte glycoprotein antibody-associated demyelinating disease in an elderly patient after long-term remission
- Open Access
- 12 June 2022
- Published by Wiley in Epilepsia Open
- Vol. 7 (3) , 431-441
Impact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study
Objective: The impact of the coronavirus disease 2019 (COVID‐19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study.Methods: This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy center‐specific monthly data divided by the 12‐month average in 2019 for each facility. We determined whether the COVID‐19 pandemic‐related factors (such as year [2019 or 2020], COVID‐19 cases in each prefecture in the previous month, and a state of emergency) were independently associated with these outcomes.Results: In 2020, the frequency of outpatient EEG studies (−10.7%, P < .001) and cases with telemedicine (+2608%, P = .031) were affected. The number of COVID‐19 cases was an independent associated factor for epilepsy admission (−3.75 × 10−3% per case, P < .001) and EEG monitoring (−3.81 × 10−3% per case, P = .004). Furthermore, a state of emergency was an independent factor associated with outpatient with epilepsy (−11.9%, P < .001), outpatient EEG (−32.3%, P < .001), telemedicine for epilepsy (+12,915%, P < .001), epilepsy admissions (−35.3%; P < .001), EEG monitoring (−24.7%: P < .001), and epilepsy surgery (−50.3%, P < .001).Significance: We demonstrated the significant impact that the COVID‐19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic‐related factor on epilepsy care.
- 12 June 2022
- Published by Wiley in Epilepsia Open
- Vol. 7 (3) , 431-441
Open AccessImpact of COVID‐19 pandemic on epilepsy care in Japan: A national‐level multicenter retrospective cohort study
Objective: The impact of the coronavirus disease 2019 (COVID‐19) pandemic on epilepsy care across Japan was investigated by conducting a multicenter retrospective cohort study.Methods: This study included monthly data on the frequency of (1) visits by outpatients with epilepsy, (2) outpatient electroencephalography (EEG) studies, (3) telemedicine for epilepsy, (4) admissions for epilepsy, (5) EEG monitoring, and (6) epilepsy surgery in epilepsy centers and clinics across Japan between January 2019 and December 2020. We defined the primary outcome as epilepsy center‐specific monthly data divided by the 12‐month average in 2019 for each facility. We determined whether the COVID‐19 pandemic‐related factors (such as year [2019 or 2020], COVID‐19 cases in each prefecture in the previous month, and a state of emergency) were independently associated with these outcomes.Results: In 2020, the frequency of outpatient EEG studies (−10.7%, P < .001) and cases with telemedicine (+2608%, P = .031) were affected. The number of COVID‐19 cases was an independent associated factor for epilepsy admission (−3.75 × 10−3% per case, P < .001) and EEG monitoring (−3.81 × 10−3% per case, P = .004). Furthermore, a state of emergency was an independent factor associated with outpatient with epilepsy (−11.9%, P < .001), outpatient EEG (−32.3%, P < .001), telemedicine for epilepsy (+12,915%, P < .001), epilepsy admissions (−35.3%; P < .001), EEG monitoring (−24.7%: P < .001), and epilepsy surgery (−50.3%, P < .001).Significance: We demonstrated the significant impact that the COVID‐19 pandemic had on epilepsy care. These results support those of previous studies and clarify the effect size of each pandemic‐related factor on epilepsy care.
- Open Access
- 5 October 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 125, 108361
Risk factors for psychological distress in electroencephalography technicians during the COVID-19 pandemic: A national-level cross-sectional survey in Japan
- 5 October 2021
- Published by Elsevier in Epilepsy & Behavior
- Vol. 125, 108361
Open AccessRisk factors for psychological distress in electroencephalography technicians during the COVID-19 pandemic: A national-level cross-sectional survey in Japan